Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Friedman

Showing results (111-120 of 241) with videos related to

Pageof 25
Sort By:
Journal of Drugs in Dermatology : JDD|July 6, 2023
Nitric Oxide as a Promising Antiviral Agent: What Dermatologists Should kNOwErika T McCormick, Sapana Desai, Adam Friedman
JAMA Dermatology|November 2, 2018
Evaluation of Prevention Interventions for Taxane-Induced Dermatologic Adverse Events: A Systematic ReviewDustin H Marks, Azam Qureshi, Adam Friedman
Journal of Drugs in Dermatology : JDD|September 4, 2024
Pioneers in Sensitive Skin Research: The Global Sensitive Skincare Faculty by GaldermaCleo Whiting, Sara Abdel Azim, Adam Friedman
American Journal of Clinical Dermatology|January 22, 2024
The Skin Microbiome and its Significance for DermatologistsCleo Whiting, Sara Abdel Azim, Adam Friedman
Journal of Drugs in Dermatology : JDD|October 6, 2023
Updates in the Treatment of Body-Focused Repetitive DisordersCleo Whiting, Sara Abdel Azim, Adam Friedman
Cureus|September 4, 2023
A Mysterious Recurrent Urticarial Rash and a Life-Altering MetalAdam Friedman, Olga Schweiker-Kahn, Satyajeet Roy
Journal of Drugs in Dermatology : JDD|September 8, 2022
Nontraditional Healing Utilization and Disclosure Among Dermatology Patients: A National Cross-Sectional Survey StudyKaushik Venkatesh, Gabriel Brito, Kamaria Nelson, et al.
Journal of Drugs in Dermatology : JDD|December 4, 2024
Recognizing and Advancing Leadership in Dermatology: Promoting the Health Care Administration, Leadership, and Management SubspecialtyKaushik P Venkatesh, Adam Friedman, Vinod E Nambudiri
American Journal of Disaster Medicine|February 18, 2025
Correlation between wildfires and atopic dermatitis and the impact on low socioeconomic populationsPeter Baek, Emily Murphy, Karl Saardi, et al.
JAAD Case Reports|March 9, 2026
Bimekizumab for recalcitrant pyoderma gangrenosumChristina Tolete, Adam Friedman, Joaquin Calderon, et al.
Pageof 25

Showing results (111-120 of 241) with videos related to

Sort By:
Pageof 25
Journal of Drugs in Dermatology : JDD|July 6, 2023
Nitric Oxide as a Promising Antiviral Agent: What Dermatologists Should kNOwErika T McCormick, Sapana Desai, Adam Friedman
JAMA Dermatology|November 2, 2018
Evaluation of Prevention Interventions for Taxane-Induced Dermatologic Adverse Events: A Systematic ReviewDustin H Marks, Azam Qureshi, Adam Friedman
Journal of Drugs in Dermatology : JDD|September 4, 2024
Pioneers in Sensitive Skin Research: The Global Sensitive Skincare Faculty by GaldermaCleo Whiting, Sara Abdel Azim, Adam Friedman
American Journal of Clinical Dermatology|January 22, 2024
The Skin Microbiome and its Significance for DermatologistsCleo Whiting, Sara Abdel Azim, Adam Friedman
Journal of Drugs in Dermatology : JDD|October 6, 2023
Updates in the Treatment of Body-Focused Repetitive DisordersCleo Whiting, Sara Abdel Azim, Adam Friedman
Cureus|September 4, 2023
A Mysterious Recurrent Urticarial Rash and a Life-Altering MetalAdam Friedman, Olga Schweiker-Kahn, Satyajeet Roy
Journal of Drugs in Dermatology : JDD|September 8, 2022
Nontraditional Healing Utilization and Disclosure Among Dermatology Patients: A National Cross-Sectional Survey StudyKaushik Venkatesh, Gabriel Brito, Kamaria Nelson, et al.
Journal of Drugs in Dermatology : JDD|December 4, 2024
Recognizing and Advancing Leadership in Dermatology: Promoting the Health Care Administration, Leadership, and Management SubspecialtyKaushik P Venkatesh, Adam Friedman, Vinod E Nambudiri
American Journal of Disaster Medicine|February 18, 2025
Correlation between wildfires and atopic dermatitis and the impact on low socioeconomic populationsPeter Baek, Emily Murphy, Karl Saardi, et al.
JAAD Case Reports|March 9, 2026
Bimekizumab for recalcitrant pyoderma gangrenosumChristina Tolete, Adam Friedman, Joaquin Calderon, et al.
Pageof 25